Browse
related articles
Lifestyle illnesses boost Hikma sales
- Jordan: Sunday, August 30 - 2009 at 10:29
Jordan-based Hikma Pharmaceuticals has said that sales of drugs to treat lifestyle-related chronic diseases now account for more than half of its sales in the Middle East, where it makes more than two-thirds of its annual turnover, the Financial Times has reported. Increasingly westernised lifestyles amongst people in the Middle East have led to rising sales of hypertension and diabetes drugs, Said Darwazah, Hikma's chief executive said. "Countries such as the UAE, Bahrain and the Gulf countries are having serious problems with diabetes, so we are launching a big portfolio of anti-diabetic products."
Related Content
Article Options
StaffSunday, August 30 - 2009 at 10:29 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
